Coding variants in RPL3L and MYZAP increase risk of atrial fibrillation

Rosa B Thorolfsdottir, Gardar Sveinbjornsson, Patrick Sulem, Jonas B Nielsen, Stefan Jonsson, Gisli H Halldorsson, Pall Melsted, Erna V Ivarsdottir, Olafur B Davidsson, Ragnar P Kristjansson, Gudmar Thorleifsson, Anna Helgadottir, Solveig Gretarsdottir, Gudmundur Norddahl, Sridharan Rajamani, Bjarni Torfason, Atli S Valgardsson, Jon T Sverrisson, Vinicius Tragante, Oddgeir L HolmenFolkert W Asselbergs, Dan M Roden, Dawood Darbar, Terje R Pedersen, Marc S Sabatine, Cristen J Willer, Maja-Lisa Løchen, Bjarni V Halldorsson, Ingileif Jonsdottir, Kristian Hveem, David O Arnar, Unnur Thorsteinsdottir, Daniel F Gudbjartsson, Hilma Holm, Kari Stefansson

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Most sequence variants identified hitherto in genome-wide association studies (GWAS) of atrial fibrillation are common, non-coding variants associated with risk through unknown mechanisms. We performed a meta-analysis of GWAS of atrial fibrillation among 29,502 cases and 767,760 controls from Iceland and the UK Biobank with follow-up in samples from Norway and the US, focusing on low-frequency coding and splice variants aiming to identify causal genes. We observe associations with one missense (OR = 1.20) and one splice-donor variant (OR = 1.50) in RPL3L, the first ribosomal gene implicated in atrial fibrillation to our knowledge. Analysis of 167 RNA samples from the right atrium reveals that the splice-donor variant in RPL3L results in exon skipping. We also observe an association with a missense variant in MYZAP (OR = 1.38), encoding a component of the intercalated discs of cardiomyocytes. Both discoveries emphasize the close relationship between the mechanical and electrical function of the heart.

Original languageEnglish
Article number68
JournalCommunications biology
Volume1
Issue number1
DOIs
Publication statusPublished - 2018

Fingerprint

Dive into the research topics of 'Coding variants in RPL3L and MYZAP increase risk of atrial fibrillation'. Together they form a unique fingerprint.

Cite this